Future of Personalized Psychiatry – The Integrative Omics Strategy in Diagnosis and Treatment of Mental Disorders

Articles

ORIGINAL RESEARCH

Published on 19 Aug 2022

Associations of cognitive impairment in patients with schizophrenia with genetic features and with schizophrenia-related structural and functional brain changes

ORIGINAL RESEARCH

Published on 29 Jul 2022

Metabolic risk factors of cognitive impairment in young women with major psychiatric disorder

MINI REVIEW

Published on 27 May 2022

Current State of Fluid Lipid Biomarkers for Personalized Diagnostics and Therapeutics in Schizophrenia Spectrum Disorders and Related Psychoses: A Narrative Review

ORIGINAL RESEARCH

Published on 25 Apr 2022

Proteomic Analysis of Plasma Markers in Patients Maintained on Antipsychotics: Comparison to Patients Off Antipsychotics and Normal Controls

ORIGINAL RESEARCH

Published on 15 Apr 2022

Schizophrenia Risk Mediated by microRNA Target Genes Overlapped by Genome-Wide Rare Copy Number Variation in 22q11.2 Deletion Syndrome

Share on

Frontiers in Psychiatry

Submit your idea

Articles

Associations of cognitive impairment in patients with schizophrenia with genetic features and with schizophrenia-related structural and functional brain changes

Metabolic risk factors of cognitive impairment in young women with major psychiatric disorder

Current State of Fluid Lipid Biomarkers for Personalized Diagnostics and Therapeutics in Schizophrenia Spectrum Disorders and Related Psychoses: A Narrative Review

Proteomic Analysis of Plasma Markers in Patients Maintained on Antipsychotics: Comparison to Patients Off Antipsychotics and Normal Controls

Schizophrenia Risk Mediated by microRNA Target Genes Overlapped by Genome-Wide Rare Copy Number Variation in 22q11.2 Deletion Syndrome

Frontiers in Psychiatry